Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorOruç, Muhammet Ali
dc.contributor.authorÖzdemir, Şule
dc.contributor.authorÖztomurcuk, Derya
dc.date.accessioned2023-08-11T13:37:19Z
dc.date.available2023-08-11T13:37:19Z
dc.date.issued2022en_US
dc.identifier.citationOruç, M. A., Ozdemir, S., & Oztomurcuk, D. (2022). Characteristics of tuberculosis-related deaths and risk factors: a retrospective cohort study in Samsun province of Turkey. Postgraduate Medicine, 134(2), 217-223.en_US
dc.identifier.issn00325481
dc.identifier.urihttps://doi.org/10.1080/00325481.2022.2029106
dc.identifier.urihttps://hdl.handle.net/20.500.12513/5291
dc.description.abstractObjectives: Tuberculosis (TB) remains one of the top ten leading causes of death worldwide despite effective therapy. The present study aims to examine the characteristics of TB-related deaths in Samsun Province and to determine the risk factors. Methods: In this retrospective registry-based cohort study, the medical records of patients registered with Samsun Tuberculosis Control Dispensary between 1 January 2018 and 31 December 2019 were retrospectively reviewed. The Cox proportional-hazards model was used to determine the factors associated with the risk of death in patients with TB. Results: The treatment outcomes of a total of 382 patients were reviewed. It was found that the treatment was successful in 346 patients (90.6%), and 31 patients (8.1%) died before or during TB therapy. The median survival time of patients who died during the therapy was 1.86 months (95% CI = 0.07–5.17 months), and more than 50% (13/25) of the deaths occurred in the first two months of the treatment. Age above 70 years (HR 15.06 (3.33–67.95)), male gender (HR 2.74 (1.02–7.33)), pulmonary TB (HR 2.92 (1.002–8.52)), multidrug-resistant (MDR) tuberculosis (HR 1.69 (1.22–12.75)), and a delay in the treatment of more than ten days (HR 2.71 (1.22–6.04)) were identified as risk factors associated with mortality in TB patients (p < 0.05). Conclusion: The majority of deaths in our cohort occurred within the first two months after starting the treatment. Advanced age, male sex, a new diagnosis of TB, pulmonary TB, MDR-TB, and a treatment delay of more than ten days after diagnosis increased the risk for mortality during antituberculosis treatment. © 2022 Informa UK Limited, trading as Taylor & Francis Group.en_US
dc.language.isoengen_US
dc.publisherTaylor and Francis Ltd.en_US
dc.relation.isversionof10.1080/00325481.2022.2029106en_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjecthealth policyen_US
dc.subjectmortalityen_US
dc.subjectrisk factoren_US
dc.subjectTuberculosis controlen_US
dc.titleCharacteristics of tuberculosis-related deaths and risk factors: a retrospective cohort study in Samsun province of Turkeyen_US
dc.typearticleen_US
dc.relation.journalPostgraduate Medicineen_US
dc.contributor.departmentTıp Fakültesien_US
dc.contributor.authorIDŞule Özdemir / 0000-0002-0366-7455en_US
dc.identifier.volume134en_US
dc.identifier.issue2en_US
dc.identifier.startpage217en_US
dc.identifier.endpage223en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster